Misoprostol for primary versus secondary prevention of postpartum haemorrhage: a cluster-randomised non-inferiority community trial.

MLA

Raghavan, S., et al. “Misoprostol for Primary versus Secondary Prevention of Postpartum Haemorrhage: A Cluster-Randomised Non-Inferiority Community Trial.” BJOG: An International Journal of Obstetrics & Gynaecology, vol. 123, no. 1, Jan. 2016, pp. 120–27. EBSCOhost, https://doi.org/10.1111/1471-0528.13540.

APA

Raghavan, S., Geller, S., Miller, S., Goudar, S., Anger, H., Yadavannavar, M., Dabash, R., Bidri, S., Gudadinni, M., Udgiri, R., Koch, A., Bellad, M., Winikoff, B., Goudar, S. S., Yadavannavar, M. C., Bidri, S. R., Gudadinni, M. R., Koch, A. R., & Bellad, M. B. (2016). Misoprostol for primary versus secondary prevention of postpartum haemorrhage: a cluster-randomised non-inferiority community trial. BJOG: An International Journal of Obstetrics & Gynaecology, 123(1), 120–127. https://doi.org/10.1111/1471-0528.13540

Chicago

Raghavan, S, S Geller, S Miller, Ss Goudar, H Anger, Mc Yadavannavar, R Dabash, et al. 2016. “Misoprostol for Primary versus Secondary Prevention of Postpartum Haemorrhage: A Cluster-Randomised Non-Inferiority Community Trial.” BJOG: An International Journal of Obstetrics & Gynaecology 123 (1): 120–27. doi:10.1111/1471-0528.13540.